FDA approves 1st mRNA flu shot, from Moderna

The Food and Drug Administration on Wednesday approved the U.S.’s first flu shot that uses mRNA technology: mFlusiva, from drugmaker Moderna.

This report comes from NBC News. The story centres on FDA approves 1st mRNA flu shot, from Moderna. Full coverage and background context is available at the original source. Readers seeking more detail on this developing topic are encouraged to follow updates from NBC News and related outlets covering this beat.